Article

Ophthonix picks Osbaldeston as chief executive officer

Ophthonix has named Stephen J. Osbaldeston as its chief executive officer.

Key Points

San Diego-Ophthonix has named Stephen J. Osbaldeston as its chief executive officer (CEO), succeeding Andreas Dreher, PhD, who had been chairman of the board and CEO.

Dr. Dreher will retain his position as chairman of the board and take on the role of chief technology officer, where he will oversee research and development and engineering.

Osbaldeston has more than 20 years of experience in the eye-care field, including positions with CIBA Vision, where he was president, global specialty lens and lens care. He also worked at Bausch & Lomb.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Steven R. Sarkisian, Jr., MD, ABO, speaks about glaucoma at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Eric D. Donnenfeld, MD, on the effect of lifitegrast clinical signs and biomarkers in dry eye disease
(Image credit: Ophthalmology Times) The Residency Report: Clinical insights from the iStent infinite trial
(Image credit: Ophthalmology Times) ASCRS 2025: Amar Shah, MD, on why hyperosmolar tear film before and after cataract surgery matters
© 2025 MJH Life Sciences

All rights reserved.